LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear™ is proud to announce FDA approval for the Cochlear Nucleus® Hybrid Implant System. The system is a groundbreaking advancement that will change the way hearing loss is treated in the United ...

Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears. Cochlear Limited obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) just unveiled an ...

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, is proud to highlight the success of Cochlear Link, an innovative customer service offering that makes it easier for ...

Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...

LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...

The dorsal cochlear nucleus (DCN) integrates auditory nerve input with a diverse array of sensory and motor signals processed in circuitry similar to that of the cerebellum. Yet how the DCN ...